Literature DB >> 18092976

Virus recovery rates for wild-type and live-attenuated vaccine strains of African horse sickness virus serotype 7 in orally infected South African Culicoides species.

G J Venter1, J T Paweska.   

Abstract

Previously reported virus recovery rates from Culicoides (Avaritia) imicola Kieffer and Culicoides (Avaritia) bolitinos Meiswinkel (Diptera, Ceratopogonidae) orally infected with vaccine strain of African horse sickness virus serotype 7 (AHSV-7) were compared with results obtained from concurrently conducted oral infections with five recent AHSV-7 isolates from naturally infected horses from various localities in South Africa. Culicoides were fed sheep bloods spiked with 10(7.6) TCID(50)/mL of a live-attenuated vaccine strain AHSV-7, and with five field isolates in which virus titre in the bloodmeals ranged from 10(7.1) to 10(8.2) TCID(50)/mL). After an extrinsic incubation of 10 days at 23.5 degrees C, virus recovery rates were significantly higher in C. imicola (13.3%) and C. bolitinos (4.2%) infected with the live-attenuated virus than in midges infected with any of the field isolates. The virus recovery rates for the latter groups ranged from 0% to 9.5% for C. imicola and from 0% to 1.5% for C. bolitinos. The C. imicola population at Onderstepoort was significantly more susceptible to infection with AHSV-7 isolated at Onderstepoort than to the virus strains isolated from other localities. Results of this study suggest that tissue culture attenuation of AHSV-7 does not reduce its ability to orally infect competent Culicoides species and may even lead to enhanced replication in the vector. Furthermore, oral susceptibility in a midge population appears to vary for geographically distinct isolates of AHSV-7.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18092976     DOI: 10.1111/j.1365-2915.2007.00706.x

Source DB:  PubMed          Journal:  Med Vet Entomol        ISSN: 0269-283X            Impact factor:   2.739


  6 in total

Review 1.  Bluetongue in Europe: past, present and future.

Authors:  Anthony J Wilson; Philip S Mellor
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-09-27       Impact factor: 6.237

2.  Culicoides (Diptera: Ceratopogonidae) midges, the vectors of African horse sickness virus--a host/vector contact study in the Niayes area of Senegal.

Authors:  Moussa Fall; Maryam Diarra; Assane G Fall; Thomas Balenghien; Momar T Seck; Jérémy Bouyer; Claire Garros; Geoffrey Gimonneau; Xavier Allène; Iba Mall; Jean-Claude Delécolle; Ignace Rakotoarivony; Mame T Bakhoum; Ange M Dusom; Massouka Ndao; Lassana Konaté; Ousmane Faye; Thierry Baldet
Journal:  Parasit Vectors       Date:  2015-01-21       Impact factor: 3.876

3.  VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.

Authors:  Sandra G P van de Water; René G P van Gennip; Christiaan A Potgieter; Isabel M Wright; Piet A van Rijn
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

Review 4.  Adaptive strategies of African horse sickness virus to facilitate vector transmission.

Authors:  Anthony Wilson; Philip Scott Mellor; Camille Szmaragd; Peter Paul Clement Mertens
Journal:  Vet Res       Date:  2008-12-19       Impact factor: 3.683

5.  Seasonal dynamics of Culicoides (Diptera: Ceratopogonidae) biting midges, potential vectors of African horse sickness and bluetongue viruses in the Niayes area of Senegal.

Authors:  Maryam Diarra; Moussa Fall; Assane G Fall; Aliou Diop; Momar Talla Seck; Claire Garros; Thomas Balenghien; Xavier Allène; Ignace Rakotoarivony; Renaud Lancelot; Iba Mall; Mame Thierno Bakhoum; Ange Michel Dosum; Massouka Ndao; Jérémy Bouyer; Hélène Guis
Journal:  Parasit Vectors       Date:  2014-03-31       Impact factor: 3.876

6.  Assessing the potential of plains zebra to maintain African horse sickness in the Western Cape Province, South Africa.

Authors:  Thibaud Porphyre; John D Grewar
Journal:  PLoS One       Date:  2019-10-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.